Related Experiment Video
Updated: Jun 17, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
Published on: May 17, 2016
Nuclear function of Smad7 promotes myogenesis
Tetsuaki Miyake1, Nezeka S Alli, John C McDermott
1Department of Biology, York University, St., Toronto, Ontario M3J 1P3, Canada.
Abstract:
In the "canonical" view of transforming growth factor beta (TGF-beta) signaling, Smad7 plays an inhibitory role. While Smad7 represses Smad3 activation by TGF-beta, it does not reverse the inhibitory effect of TGF-beta on myogenesis, suggesting a different function in myogenic cells. We previously reported a promyogenic role of Smad7 mediated by an interaction with MyoD. Based on this association, we hypothesized a possible nuclear function of Smad7 independent of its role at the level of the receptor. We therefore engineered a chimera of Smad7 with a nuclear localization signal (NLS), which serves to prevent and therefore bypass binding to the TGF-beta receptor while concomitantly constitutively localizing Smad7 to the nucleus. This Smad7-NLS did not repress Smad3 activation by TGF-beta but did retain its ability to enhance myogenic gene activation and phenotypic myogenesis, indicating that the nuclear, receptor-independent function of Smad7 is sufficient to promote myogenesis. Furthermore, Smad7 physically interacts with MyoD and antagonizes the repressive effects of active MEK on MyoD. Reporter and myogenic conversion assays indicate a pivotal regulation of MyoD transcriptional properties by the balance between Smad7 and active MEK. Thus, Smad7 has a nuclear coactivator function that is independent of TGF-beta signaling and necessary to promote myogenic differentiation.
Insights
Smad7 promotes muscle cell differentiation independently of TGF-beta signaling. This nuclear Smad7 function interacts with MyoD, enhancing muscle gene activation and overcoming inhibitory signals.
Area of Science:
- Molecular Biology
- Cell Signaling
- Muscle Development
Background:
- The canonical role of Smad7 in transforming growth factor beta (TGF-beta) signaling is inhibitory.
- Smad7's previously reported promyogenic role in myogenic cells suggested functions beyond TGF-beta receptor inhibition.
Purpose of the Study:
- To investigate the nuclear function of Smad7 in myogenesis, independent of its interaction with the TGF-beta receptor.
- To elucidate the mechanism by which Smad7 promotes myogenic differentiation.
Main Methods:
- Engineering of a Smad7-nuclear localization signal (NLS) chimera to ensure nuclear localization and bypass receptor binding.
- Assays to assess Smad3 activation, myogenic gene activation, and phenotypic myogenesis.
- Reporter and myogenic conversion assays to study Smad7's interaction with MyoD and MEK.
Main Results:
- Smad7-NLS enhanced myogenic gene activation and phenotypic myogenesis without repressing Smad3 activation.
- Smad7 physically interacts with MyoD and counteracts the inhibitory effects of active MEK on MyoD.
- The balance between Smad7 and active MEK critically regulates MyoD transcriptional activity.
Conclusions:
- Smad7 possesses a nuclear, TGF-beta-independent coactivator function essential for promoting myogenesis.
- Smad7's interaction with MyoD and modulation of MEK signaling are key mechanisms underlying its promyogenic activity.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Master Transcription Regulators
Satellite Stem Cells and Muscular Dystrophy
Abnormal Proliferation
Regulation of Nuclear Protein Sorting

